Is Syros Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Syros Pharmaceuticals Inc (SYRS) is currently classified as NOT HALAL as of November 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Syros Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Syros Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Syros Pharmaceuticals Inc?

Muslim investors may consider investing in Syros Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Syros Pharmaceuticals Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Syros Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Syros Pharmaceuticals Inc updated?

The Shariah compliance status of Syros Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Syros Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Syros Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Syros Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SYRS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: November 22, 2024

Report Source: 2024 3rd Quarter Report

Analyst's Ratings for Syros Pharmaceuticals Inc (SYRS)

Based on 6 analysts giving stock ratings to Syros Pharmaceuticals Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Syros Pharmaceuticals Inc. Stock Analysis SYRS

United States Health Care Nano Cap Report: Q3, 2024

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 68 full-time employees. The company went IPO on 2016-06-30. The firm is actively engaged in the voluntary delisting process. The firm was previously engaged in developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Key Statistics of Syros Pharmaceuticals Inc (SYRS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.10$0.12

Today's Open

$0.11

Volume

1724.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.12

Market Cap

5366.00

Avg. Volume

63.19M

Dividend Yield

Financial Metrics & Statements of Syros Pharmaceuticals Inc (SYRS)

FAQ's for Syros Pharmaceuticals Inc (SYRS)

According to Musaffa’s Shariah screening methodology, Syros Pharmaceuticals Inc (SYRS) is currently classified as NOT HALAL as of November 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.